東陽光長江藥業：中期報告2024.pdf

1、CONTENTS目錄2Financial Highlights財務摘要3Corporate Profile公司簡介5Management Discussion and Analysis管理層討論及分析42Corporate Governance and Other Information企業管治及其他資料50Review Report審閱報告52Consolidated Statement of Profit or Loss and Other Comprehensive Income綜合損益及其他全面收益表53Consolidated Statement of Financial Posit

2、ion綜合財務狀況表55Consolidated Statement of Changes in Equity綜合權益變動表57Condensed Consolidated Cash Flow Statement簡明綜合現金流量表59Notes to the Unaudited Interim Financial Reports未經審核中期財務報告附註94Corporate Information公司資料YICHANG HEC CHANGJIANG PHARMACEUTICAL CO.,LTD./INTERIM REPORT 20242Financial Highlights財務摘要(RMB0

3、00)（人民幣千元）Six months ended 30 June 2024截至二零二四年六月三十日止六個月Six months ended 30 June 2023截至二零二三年六月三十日止六個月Year ended 31 December截至十二月三十一日止年度 2023202220212020二零二三年二零二二年二零二一年二零二零年 Revenue營業額2,454,7623,209,0026,294,5853,744,952913,7882,348,113Gross profit毛利1,949,2322,563,9374,985,7642,846,074483,6991,996,566

4、Profit/(loss)from operations經營溢利（虧損）867,3851,398,1212,354,198321,068(423,377)1,254,640Profit/(loss)before taxation除稅前溢利（虧損）813,5311,261,8532,126,77139,422(667,184)1,010,434Profit/(loss)attributable to equity shareholders of the Company本公司權益股東 應佔溢利（虧損）684,7311,029,4951,992,62476,603(587,649)839,455Ea

5、rnings/(losses)per share每股盈利（虧損）Basic(RMB cent)基本（人民幣：分）781172.69(67)95 Diluted(RMB cent)攤薄（人民幣：分）781172.69(67)53Total assets總資產12,494,19613,444,19612,744,32911,889,80010,541,5819,561,267Total liabilities總負債3,828,8166,350,2714,808,8165,819,7994,520,8194,457,608Net assets淨資產8,665,3807,093,9257,935,51

6、36,070,0016,020,7625,103,659Profitability盈利能力Gross profit margin毛利率79.4%79.9%79.2%76.00%52.9%85.0%Operating profit margin經營溢利率35.3%43.6%37.4%8.6%46.3%53.4%Net profit margin淨利潤率27.9%31.9%29.5%1.3%-64.3%35.7%3Corporate Profile公司簡介中期報告2024 /宜昌東陽光長江藥業股份有限公司YiChang HEC ChangJiang Pharmaceutical Co.,Ltd.(